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Background/aim: Adenoid hypertrophy (AH) is chronic enlargement of the adenoid tissue. The pathophysiology of the disease is
unclear. We analyzed SCGB1D4 gene polymorphisms in order to determine the effect of the variants or their genetic combinations on
AH.
Materials and methods: We genotyped the SCGB1D4 (IIS) gene in 167 participants (95 children with AH and 72 controls) by performing
DNA sequencing in blood samples.
Results: We genotyped three single nucleotide polymorphisms (SNPs). In the analysis, we found that in the presence of those SNPs
and the minor alleles of individual SNPs four haplotypes were associated with an increased risk of AH. In addition, those SNPs
were significantly associated with asthma, allergy, sleep-disordered breathing, AH grade +4, and a high level of IgE. As indicated
on multifactor dimensionality reduction analysis, single-locus (rs35328961), two-locus (rs35328961_rs56196602), and three-locus
models (rs200327820_rs35328961_rs56196602) had the highest synergistic interaction effect on AH. The three-factor model was also
significantly associated with some genotypes of rs35328961 and allergic–asthmatic AH.
Conclusion: SNPs of SCGB1D4 and their combinations are associated with an increased risk for developing AH. We highlighted the
importance of genetic factors on AH and AH-related clinical phenotypes.
Key words: Adenoid hypertrophy, asthma, allergy, SDB, SNP, secretoglobins, SCGB1D4, DNA sequence analysis, PCR, MDR, haplotypes,
gene

1. Introduction
The adenoids, also known as pharyngeal or nasopharyngeal
tonsils, are important components of the Waldeyer’s
ring (1). Adenoid hypertrophy (AH) is enlargement of
the adenoids; it is frequent in the pediatric population
and can cause symptoms such as mouth breathing,
nasal obstruction, hyponasal speech, snoring, and sleepdisordered breathing (SDB) (2–4). The exact mechanisms
underlying AH remain extremely poorly understood, but it
has been assumed that recurrent or chronic inflammation
plays a role (5).
Cytokines, which are assigned to function in
immunological responses, may change the progress and
severity of inflammatory processes (6–8). Various genetic
factors and their combinations can affect the association
with various disease phenotypes, and change the severity

of chronic inflammatory diseases through altering the
levels of gene expression (9–11).
Secretoglobulins (SCGBs) are newly discovered
cytokines, and they are candidates to form a new
cytokine family with their anti-inflammatory and
immunomodulatory functions (12,13). They have
been reported to play a role in the pathogenesis of
inflammatory upper and lower airway diseases including
asthma, allergies, and nasal polyposis (12–14). SCGB1D4
(Secretoglobin, family 1D, member 4; IIS) gene is located
on chromosome 11 (11q12.3), and it is expressed widely
in the lymphoblasts in the airway mucosa and lymphoid
tissues. The SCGB1D4 gene, stimulated by IFN-gamma,
has been reported to regulate the migration and invasion
of chemotactic cells (12,14). To date, only a few studies
have focused on SCGB1D4.

* This study was presented at the 11th International Congress of Otorhinolaryngology and Head and Neck Surgery, Ankara, Turkey, 2014.
** Correspondence: s_unurlu@yahoo.com
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In this study, we aimed to analyze SCGB1D4 gene
polymorphisms and determine the effect of the variants,
or their genetic combinations, on AH.
2. Materials and methods
2.1. Study population
A total of 95 children with AH (39 girls and 56 boys) with
a mean age of 5.27 (3–10) years were included in the study
as the study group, and 72 healthy children (22 girls and
50 boys) with a mean age of 4.96 (2–11) years acted as
the controls. The diagnosis of AH was based on history
and physical and endoscopic examination (15). AH was
graded in accordance with Parikh’s classification: grade 1
indicated adenoid tissue not in contact with the adjacent
structures, grade 2 indicated adenoid tissue in contact
with the torus tubarius, grade 3 indicated adenoid tissue
in contact with the vomer, and grade 4 indicated adenoid
tissue in contact with the soft palate (16). In our study,
grades 3 or 4 were regarded as AH.
The control group consisted of children admitted for
their regular follow-up or minor trauma and the diagnosis
of AH was ruled out by endoscopic examination. Children
with craniofacial abnormalities, mental retardation,
immunodeficiencies, and/or cardiovascular, pulmonary,
metabolic, genetic, or neuromuscular diseases were
excluded.
The diagnosis of SDB was primarily based on the clinical
history obtained from the parents of the children (17).
Asthma diagnosis was based on history or examination
of the children in the pulmonology department (18). Skin
prick testing was used to determine allergy. The tests were
performed in accordance with the recommendations of the
European Academy of Allergy and Clinical Immunology
(19). Total serum immunoglobulin (Ig) E level was
determined by nephelometric assay (Dade Behring/
Siemens, Deerfield, IL, USA) (20).
The parents of the children were informed about the
study and the method of the study, and their verbal and
written informed consents were obtained. The study
protocol was approved by Hacettepe University Ethics
Board, and the study was conducted in accordance with
human rights and experimental ethics.
2.2. DNA isolation and genotyping
Blood samples were put into tubes with EDTA. Genomic
DNA was extracted using a ready kit (NucleoSpin blood
DNA, Macherey-Nagel GmbH & Co. Kg, Germany).
Genotyping for SCGB1D4 was performed by sequencing.
First, a polymerase chain reaction (PCR) was performed
to enhance the relevant gene region (SuperHot
Master Mix, Bioron, GmbH, Germany). The primer
pairs used in the PCR reaction were designed using
Primer Designer version 2.0 (Scientific & Educational
Software). For Exon I, the forward primer used was
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5’-CACTCAGATGCAGAGAT TC CTAAGGAG-3’
and
the
reverse
primer
was
5’-CTCTAACCTTTATGAATCTTATTCAACAAGC-3’.
A 443-bp fragment was amplified with this primer
set. For Exon II, the forward primer used was
5’-ATGAAGCTCT TC C CT T TGT TGTGTGAC-3’
and
the
reverse
primer
was
5’-CATCCCAYAGTGACCGTGTCCACTG-3’.
A
609-bp fragment was amplified with this primer
set. For Exon III, the forward primer used was
5’GAAAGGCTGCTTTCTCACCAGAATG-3’
and
the
reverse
primer
was
5’TTCAGGCCCCATTAGTAACAGAATGC-3’. A 476-bp
fragment was amplified with this primer set. The mixture
was denatured at 95 °C for 5 min and underwent 35
cycles in a thermocycler PCR system under the following
conditions: denaturation at 95 °C for 1 min, annealing at
60 °C for 45 s, extension at 72 °C for 1 min, and a final
extension at 72 °C for 10 min.
A ready kit was used for purification of the amplified
products (NucleoFast 96 PCR, Macherey-Nagel GmbH
& Co. Kg, Germany). A sequence reaction was done
in the purified PCR products with a ready kit (BigDye
Terminator V3.1 Cycle Sequencing, Applied Biosystems,
USA). The nucleotide changes in the SCGB1D4 gene were
investigated using the data obtained from the ABI PRISM
3130 Genetic Analyzer capillary automatic sequence
equipment.
2.3. Statistical analysis
The statistical analysis was carried out with SPSS 16.0
(SPSS Inc, Chicago, IL, USA). Comparisons of quantitative
variables such as age and IgE levels were made with
parametric or nonparametric tests depending on the
normality of the distribution. The chi-squared test or
Fisher’s exact test was used to assess the difference between
the SCGB1D4 polymorphisms and the clinical phenotypes.
The frequency of each genotype was tested for concordance
with the Hardy–Weinberg equilibrium (HWE) using χ2
(21). The effective sample size and statistical power were
computed using a web browser program, Genetic Power
Calculator (http://pngu.mgh.harvard.edu/~purcell/gpc/).
SNPStats
(http://bioinfo.iconcologia.net/index.
php?module=Snpstats) was used to determine the degree
of pairwise linkage disequilibrium (LD), and genotype
and haplotype analysis (22). This software provides
the odds ratio (OR) and 95% confidence interval (95%
CI). The software was regressed in a logistic model,
assuming the codominant (major homozygotes versus
heterozygotes versus minor homozygotes), the dominant
(major homozygotes versus heterozygotes plus minor
homozygotes), and the recessive (major homozygotes
plus heterozygotes versus minor homozygotes) models of
inheritance with covariates.
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The Multifactor Dimensionality Reduction (MDR)
software package (version 1.0.0, available at www.epistasis.
org) is a new statistical and computational tool described
by Hahn et al. We used it to address possible genotype–
genotype and genotype–phenotype relationships (24).
MDR is a nonparametric (i.e. no parameters are estimated)
novel approach, and it is free of any assumed genetic
model. It can detect and characterize nonlinear patterns
of gene–gene, SNP–SNP, and SNP–phenotype interactions
in genetic association studies, and it is more powerful than
the parametric statistical approaches. This method reduces
data dimensionality by pooling genotypes from multiple
SNPs into either high-risk or low-risk groups for a disease,
thereby circumventing the problem of high-order genotype
combinations with a low number of observations. It was
shown that it successfully identified combinations of
multilocus genotypes and discrete environmental factors
that are associated with diseases (25–27). P < 0.05 was
considered as significant in all statistical analyses.
3. Results
In the study group, 68 (71%) patients had grade 3 and
27 (29%) patients had grade 4 AH. The ages (P = 0.181)
and sexes (P = 0.163) of the study and the control groups
were similar. The rates for SDB, allergy, and asthma were
significantly higher in the study group (P < 0.05). Similarly,
total IgE level was significantly higher in the study group
compared to the controls (P < 0.05) (Table 1).
3.1. Genetic analyses
We identified three SNPs (rs200327820 (NM_996881.1:p.
Val5=), rs35328961 (NM_206998.1:c.243-9_243-8insA)
and rs56196602 (NM_206998.1:c.*13G>A)). Those

SNPs and were previously reported, and registered in the
dbSNP database (Short Genetic Variations Database at
http://www.ncbi.nlm.nih.gov/snp) (27,28). All genotype
distributions of the control subjects were consistent with
those expected from the HWE (all P ˃ 0.05).
Individual SNP analysis revealed that the frequencies
of the three SNPs were significantly different between the
study and the control groups. The analysis of the individual
SNPs revealed that there was a significant association of
rs200327820 and rs35328961 with presence of asthma (P
= 0.001 and P = 0.002, respectively) and grade 4+ AH (P
= 0.023 and P = 0.014, respectively). A similar association
of the rs56196602 was found with allergy and SDB (P =
0.040 and P = 0.012, respectively). The rs35328961 showed
a significant association with IgE level (P = 0.02). However,
sex and age did not show any associations with SNPs of
SCGB1D4 (P > 0.05).
The genotype analysis showed that the genotype
frequencies of the three SNPs were not similar in the study
and the control groups (Table 2). The analyses revealed
that rs200327820 GA, AA, and GA-AA genotypes were
associated with a significantly higher risk of AH compared
to the controls (P = 0.0051, P = 0.0012, and P = 0.00233,
respectively). In addition, the frequency of rs200327820
GA-AA genotype was higher in asthmatic children
with AH when compared to the asthmatic controls (P =
0.0011). The rs35328961 –A, AA, -A-AA, and -- genotypes
increased the risk of AH significantly when compared to
the controls (P = 0.008, P = 0.008, P = 0.023, and P = 0.036,
respectively) and in AH patients that had higher IgE levels
when compared to the controls (P = 0.0079, P = 0.0069,
P=0.0021, and P = 0.036, respectively). The frequencies of

Table 1. Characteristics of the study population.
Variables

Study group (n: 95)
n (%)

Control group (n: 72)
n (%)

P-value*

Age (years) (mean ± SD)

5.27 (1.46913; 3–10)

4.96 (1.56983; 2–11)

0.181

Sex

56 (59)/39 (41)

50 (69)/22 (31)

0.163

AH grade
+3

68 (71)

+4

27 (29)

SDB (+)

71 (75)

10 (10)

<0.001

IgE, μg/L

11.3700 (10.78601; 0.38–49.30)

9.0550 (6.33587; 0.38–32.90)

<0.001

Asthma (+)

23 (24)

5 (7)

0.003

Allergy (+)

28 (29)

7 (10)

0.003

Values are presented as median ± SD or numbers (%) unless otherwise specified; SD = Standard deviation; SDB =
Sleep-disordered breathing; n (%) = Frequency
*Derived from chi-squared or Fisher exact test for comparison of discrete variables and unpaired Student’s t-test for
continuous variables.
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Table 2. Frequencies of SCGB1D4 SNPs genotype and allele.

SNPs

rs200327820

rs35328961

rs56196602

Study group (n: 95)

Controls (n: 72)

n (%)

n (%)

GG

86 (91)

72 (100)

GA

8 (8)

0 (0)

AA

1 (1)

0 (0)

GG

86 (91)

72 (100)

GA-AA

9 (9)

0 (0)

GG-GA

94 (99)

72 (100)

AA
GG-AA

1 (1)

0 (0)

87 (92)

72 (100)

GA

8 (8)

0 (0)

Aǂ

0.053

0

Genotype/Allele

Models

OR (95 CI)*
1.00 (reference)

Codominant

8.0051 (4.01–12.02)

Dominant

1.00 (reference)

0.0012

9 (4.50–13.5)
Recessive

1.00 (reference)
1 (0.00–1.5)

Overdominant

1.00 (reference)

0.29
0.0023

8 (4.60–12.60)
0.003**

--

33 (35)

42 (59)

1.00 (reference)

47 (49)

24 (33)

2.49 (1.27–4.87)

AA

15 (16)

6 (8)

--

33 (35)

42 (58)

-A-AA

62 (65)

30 (42)

---A

80 (84)

66 (92)

AA

15 (16)

6 (8)

---AA

48 (51%)

48 (67)

--

47 (49)

24 (33)

Aǂ

0.41

0.26

GG

84 (88)

70 (93)

GA

9 (10)

2 (7)

AA

2 (2)

0 (0)

GG

84 (88)

70 (97)

GA-AA

11 (12)

2 (3)

GG-GA

93 (99)

72 (100)

AA
GG-AA

2 (2)

0 (0)

86 (91)

70 (97)

9 (9)

2 (3)

0.08

0.02

Aǂ

0.0051

1 (0.00–1.5)

-A

GA

P-value**

Codominant
Dominant
Recessive
Overdominant

0.0008

3.18 (1.11–9.10)
1.00 (reference)

0.0023

2.63 (1.40–4.94)
1.00 (reference)

0.14

2.06 (0.76–5.61)
1.00 (reference)

0.036

1.96 (1.04–3.69)
0.005
1.00 (reference)

Codominant

1.40 (0.45–4.38)

0.56

1 (0.00–2.5)
Dominant
Recessive
Overdominant

1.00 (reference)

0.026

4.58 (0.98–21.37)
1.00 (reference)
1 (0.00–1.5)
1.00 (reference)

0.13
0.07

3.66 (0.77–17.50)
0.013

n (%) = Frequency; NA = Not available; SNP = Single nucleotide polymorphism; OR = Odds ratio; CI = Confidence interval
*According to chi-squared test
**According to Fisher’s exact test;
ǂ Assumed risk alleles.

the rs35328961 --, -A-AA genotypes were higher in AH
patients with SDB when compared to the controls with
SDB (for rs35328961 -- -- P = 0.0019; for rs35328961 -AAA P = 0.0022). The frequency of rs56196602 GA-AA
genotype was significantly higher in the children with AH
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(P = 0.026), and it was also higher in allergic children with
AH when compared to the allergic controls (P = 0.027).
There were significant differences between the study
and control groups for the frequencies of rs200327820 A,
rs35328961 A, and rs56196602 A alleles (P = 0.003, P =
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0.005, P = 0.013, respectively) (Table 2). In order to reveal
the potential interactions of those three SNPs with the
risk of AH, we combined them based on the numbers of
variant (risk) alleles. In the logistic regression model, “A”
alleles together at rs200327820 and rs35328961 had 4.076fold increased risk for AH (P = 0.03).
We found that the rs35328961 and rs56196602 had
the highest pairwise LD compared to other pairwise
LD (D’= 0.3341, D’= 0.218, and D’= 0.0121). Haplotype
analysis including three SNPs was performed, and it was
seen that there were significant associations among some
haplotypes and AH (P = 0.0052) (Table 3). The frequencies
of GAG, G-A, AAG and A-G haplotypes were significantly
higher in the study group (P = 0.002, P = 0.001 and P =
0.001, respectively), but the frequency of GAA haplotype
was significantly higher in the controls when compared to
the common haplotype G-G (P = 0.031) (SCGB1D4, three
SNPs were ordered from 5′ to 3′). We also found that the
frequency of the GAG haplotype was significantly higher
in asthmatic-AH, allergic-AH, and AH with SDB in the
study group when compared to the controls (P = 0.0026
for asthma, P = 0.0001 for allergy, and P = 0.0001 for SDB).
Similarly, the frequency of the GAG haplotype was higher
in patients with a high IgE level when compared to the
controls (P = 0.0025).
3.2. SNP–SNP interactions
We used MDR, an analytical data-mining approach, to
explore the potential interactions of three individual SNPs
in the SCGB1D4 gene (27,28). The best model across all
possible combinations was assessed by testing balanced
accuracy (TBA), cross-validation consistency (CVC), and
significance level. MDR analysis indicated four predictive
models for AH. The single-locus model (rs35328961) was

one of the best attributes for risk prediction of AH with
a TBA of 61.8% and CVC of 10/10 (P = 0.002) (Figure
1). Homozygous individuals for the wild-type allele in
the SNP were located in the low-risk group while the
genotypes with “A” allele were located in high-risk group
for AH. Among all predicted models, the two-locus model
(rs35328961_rs56196602) was the second best significant
attribute for predicting the risk of AH, with a TBA of
64.4% and a CVC of 10/10 (P = 0.002). In those SNPs, the
combination of homozygous genotype for the wild-type
was higher in the control group, and associated with 1.5fold more protection against AH. The three-locus model
(rs56196602_rs200327820_rs35328961) was the third
best significant attribute for prediction of AH risk, with
a TBA of 64.4% and a CVC of 10/10 (P = < 0.0001). The
combination of homozygous genotype for the wild-type in
all three SNPs was placed in the low-risk group, and was
associated with 1.7-fold increased protection against AH.
The other interaction model that was determined
empirically by permutation testing was the three-factor
model, in which rs35328961, allergy, and asthma were
combined. This model had a TBA of 58.4% and a CVC of
7/10, and it may be associated with a high risk and a low
risk for AH, depending on the presence of asthma (P ≤
0.0001) (Figure 2A). The combinations of the rs3532896
-A, AA genotypes, and allergic asthma were placed in the
high-risk group. The dendrograms provided by MDR were
examined to help visualization and interpretation of the
potential genotype–genotype and genotype–phenotype
interactions (29). The dendrogram demonstrates the
nature of the interactions between the rs35328961, asthma,
and allergy, and the synergistic association of those three
factors for predicting susceptibility to AH (Figure 2B).

Table 3. Associations between the risk for adenoid hypertrophy and the frequencies of haplotypes based on SCGB1D4 variants.

No.
1

Haplotypes*

Haplotype frequencies

rs200327820

rs35328961

rs56196602

Study group

Controls

G

-

G

0.5516

0.7263

Cure OR (95% CI)**

P-value***

1.00 (reference)

---

2

G

A

G

0.3516

0.239

2.31 (1.37–3.88) .002

0.002

3

G

-

A

0.0523

0

1.15 (0.18–6.05)

<0.001

4

G

A

A

0.0139

0.0141

2.91 (0.38–22.26)

0.31

5

A

A

G

0.0256

NA

NA

<0.001

6

A

-

G

0.0238

NA

NA

<0.001

Values are presented as median ± SD or numbers (%) unless otherwise specified; SD = Standard deviation; SDB = Sleep-disordered
breathing; OR = Odds ratio; CI = Confidence interval; NA = Not available,
*The alleles of haplotypes were arrayed as the location of in the SNPs SCGB1D4,
**In logistic regression model,
***Global haplotype association P-value = 0.0052.

205

ÖZDAŞ et al. / Turk J Med Sci

Figure 1. Distribution of the rs35328961 genotype in the study and control groups on MDR.
Single-locus model demonstrating the effect of the rs35328961, which is able to correctly
predict AH with 61.8% accuracy. The rs35328961 GA and AA genotypes had a 1.9-fold and 2.5fold increased risk for AH, respectively. For each genotype, the number of cases is displayed in
the histogram on the left in each cell while the number of controls is displayed in the histogram
on the right. Darker shade indicates the high-risk group (TBA: 0.618, CVC 10/10, OR 2.6303,
CI 1.3998–4.9426, P = 0.002).

4. Discussion
We investigated the effects of the genetic variants of the
SCGB1D4 gene, and conducted an association study. To the
best of our knowledge, this is the first study that correlated
SCGB1D4 polymorphisms, haplotypes, and SNP–SNP
interactions with AH in a Turkish population. In our study,
three polymorphisms (rs200327820, rs35328961, and
rs56196602) were detected. We found that the presence
of those SNPs and minor alleles in each SNP and their
combinations were associated with an increased risk for
AH. In addition, those SNPs were significantly associated
with asthma, allergy, SDB, and high IgE levels in children
with AH.
rs200327820 is located in the second exon of the gene
(27). It alters the 5th codon from GTG to ATG, both of
which code for the amino acid valine. We found that
all inheritance models except recessive genotypes with
presence of a minor allele at rs200327820 were associated
with an increased risk for AH. Furthermore, we found that
carriers of the minor allele at rs200327820 had a higher
risk for AH when compared to the noncarriers. In the
present study, we showed that AH was associated with
rs200327820 GA, AA, and GA-AA genotypes in Turkish
children. The presence of GA-AA genotype increased risk
for asthma +AH 15.3-fold.
Similar to other secretory proteins, SCGB1D4 has
a hydrophobic N-terminal region with a 20 amino
acid signal peptide sequence, which is required for its
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channeling into the target organelle. (http://www.uniprot.
org/uniprot/Q6XE38#section_seq). The minor allele of
this synonymous SNP (sSNP), which does not change
the amino acid sequence, might lead to the vitiated signal
activity of the protein through influencing gene expression
biology and posttranscriptional regulation mechanisms
involving conformation and stability of pre-mRNA,
translation initiation, and stability and folding of protein
(30,31). Therefore, the gene may be a modifying factor for
AH. However, further functional studies should be carried
out to determine the clinical significance of the SNP on
AH.
The rs35328961 is an intronic SNP (27). In this study,
we found that the subjects with presence of the minor allele
of rs35328961 in all inheritance models except recessive
one were significantly associated with AH. Moreover, we
found that carrier insertion of A allele at rs35328961 was
higher in patients with AH and in patients with higher
IgE levels compared to noncarriers, and in patients with
AH with SDB when compared to the controls with SDB.
Similarly, MDR analysis showed that the insertion of A
allele at rs35328961 genotypes was associated with AH.
Introns are elements that include intron splice
enhancers and silencers, as well as the cis-acting RNA
elements that regulate alternative splicing. Some
intronic SNPs are known to have the potential to confer
susceptibility to disease, and these may be much more
common than hitherto realized (32). Approximately
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Figure 2. Distribution of the rs35328961 genotype, asthma, and allergy combinations in the study and the control
groups on MDR. A) The rs35328961 genotypes, asthma, and allergy combination, which are able to correctly predict
AH with 58.4% accuracy. The SCGB1D4 --, -A, and AA genotypes had a ∞-fold, 7-fold, and ∞-fold increased risk of
allergic-asthmatic AH, respectively. For each genotype combination, the number of cases with asthma and allergy
(positive skin prick test) or without asthma and allergy (negative skin prick test) is displayed in the histogram on the
left in each cell while the number of controls with asthma and allergy (positive skin prick test) or without asthma
and allergy (negative skin prick test) is displayed by the histogram on the right. Darker shade indicates the high-risk
group. The pattern of high and low risk for the allergy presence (negative or positive skin prick test) differs depending
on the presence of the asthma and value of the rs35328961 (TBA 0.584, CVC 7/10, OR 3.79, CI 1.9866–7.2425, P
= < 0.0001). B) The dendrogram demonstrates the nature of the interactions between the rs35328961, asthma, and
allergy included in the genetic classifier obtained by MDR. There was a synergistic interaction, with the strongest
interaction between the rs35328961, allergy, and asthma.

15% of disease-causing SNPs directly affect pre-mRNA
splicing. Single base substitutions localized at the exon–
intron boundaries can impair one of the cis-transcriptional
elements known as exonic splicing enhancers, and thereby

affect normal pre-mRNA splicing (33). However, proper
interpretation of the effects of polymorphisms might be
difficult, especially when they result in noncoding variants
(34). We suggest that the minor allele of this intronic SNP
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may impact upon the exon splicing ability, and contribute
to the risk of AH. However, in vitro assays should be
performed to elucidate the potential clinical significance
of the SNP.
The rs56196602 is located in the 3‘UTR region of the
gene (27). In the present study, we showed that AH was
associated with the rs56196602 GA-AA genotype more
when compared to those possessing other genotypes, and
it was more common in cases of allergy + AH. Additionally,
we found that the carriers of the minor allele at rs56196602
had AH more frequently when compared to noncarriers.
As this SNP is located within the 3’ flanking region, it
does not cause a residual change in the SCGB1D4 protein.
The intrinsic stability of mRNA species is determined
by cis-acting sequences located within the mRNA (often
in the 3-UTR), as well as trans-acting RNA binding
proteins (34). As such, the SNPs may alter the binding
of these trans-acting factors and stability of pre-mRNA
polyadenylation site selection, and thus influence mRNA
half-life to contribute to the pathogenesis of AH. However,
further functional analyses should be carried out to verify
the effect of the variant in gene expression.
Allergy is an important risk factor for AH in children
(5). On MDR analysis, we found that combination of
the rs35328961-A genotype and nonallergic asthma
increased the risk of AH 1.5-fold, but the combination of
rs35328961-A genotype and allergic asthma increased the
risk of AH 7-fold. Since those phenotypes affect airways
where mucosa presents similarities, they likely share a
common genetic background (35). Therefore SCGB1D4
rs35328961 gene expressed remarkably in the lymphoid
tissues may be a modifying factor for AH and allergic
asthma with AH. On the other hand, environmental
influence may be a crucial factor in the progression of AH
and related clinical phenotypes (3–5). Therefore, further
studies focusing on the gene–environment interactions of
AH, allergy, and asthma are needed to further enlighten
the pathophysiology. Recent studies found that SDB
(3), asthma (36), and allergy (5) were associated with
each other. Increased airway inflammation is evident in
those phenotypes, which promotes AH (37). Therefore,
associations of similar genotypes, haplotypes, and their
combinations with AH and related clinical phenotypes
such as SDB, asthma, and allergy are not surprising, and
we showed the role of SCGB1D4’s SNP in the molecular
mechanisms underlying AH.
Haplotypes are more powerful discriminators between
the study and control groups in disease association studies,
and they may provide more information regarding the
effect of genetic interactions on disease phenotypes rather
than genotypes (38). On haplotype analysis, we found
that the haplotypes GAG, G-A, AAG, and A-G were more
frequent in the study group and associated with AH in
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the population studied, but the haplotype GAA seemed
to protect the individual from AH. We found that the
frequency of the haplotype GAG, which was defined by
the common allele at rs200327820, and a rare allele at
rs35328961 was associated with AH. We also found that
the haplotype AAG, which was defined by the rare alleles
of rs200327820 and rs3532896, was also associated with
AH. The haplotype AAG, which was defined by rare
alleles of those SNPs, was only observed in the study
group. Notably, genotypes defined by the rare alleles at
rs200327820 and rs35328961 were associated with an
increased risk of AH and AH-related phenotypes. The
GAG haplotype was significantly associated with allergy,
asthma, high IgE level, and SDB in children with AH.
Those results are consistent with each other, and show
the potential clinical significance of rs200327820 and
rs35328961 in AH. However, the functions of the SNPs
and haplotypes remain to be elucidated.
Multiple genetic variants might have synergistic effects
beyond main effects or pairwise effects. In the current
study, we used a data mining approach, MDR, which is
able to detect interactions in the absence of main effects,
where LD and other traditional approaches are not able
to detect and characterize combinations of attributes that
interact to influence AH and AH-related phenotypes (1
+ 1 = 3 principle) (23–26). Based on the MDR method,
four predictive models for AH were observed with a P
value of 0.05, suggesting that the power of those SNPs
very strongly predicted the susceptibility to AH. When
tested independently, those three SNPs were found to be
associated with AH. Those polymorphisms may play a role
in the pathogenesis of AH.
Among the models with different loci tested, the best
genotype–genotype and genotype–phenotype models
identified were single-locus, two-locus, and three-locus
models including three SNPs, and the three-factor model
including rs35328961, asthma, and allergy. The twolocus model included rs35328961 and rs56196602. The
LD between rs35328961 and rs56196602 was stronger
than other pairwise LDs. The three-locus model included
rs200327820, rs35328961, and rs56196602. We found
that the haplotypes GAG and G-A were more frequent
in the study group, and associated with AH on haplotype
analysis. On MDR, those findings were consistent with
each other. It was also observed that all SNPs included
in the study had synergistic effects with each other. This
further corroborates that the pathogenesis of AH involves
interplay of a variety of susceptible alleles and external
stimuli, which, in turn, may influence disease severity
and natural history. Individuals may also differ in their
susceptibility to environmental risk factors, and hence
the role of gene–environment interaction on AH needs
to be clarified. However, as different populations have
distinct genetic backgrounds, it is necessary to validate or
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replicate such associations with independent and larger
samples collected especially from other ethnic groups or
populations.
There are a number of possible extensions of this study
in which we intended to collect representative data and to
consider in our future work. Thus, analysis of haplotypes
and LD, and use of MDR analysis in the present study
gives an insight into the possible interactions between the
polymorphisms of SCGB1D4 and susceptibility to AH.
Furthermore, the studies on SCGB1D4 are somewhat
scarce, and the SCGB1D4’s SNPs potential relationships
with AH and AH-related clinical phenotypes have been
studied for the first time in the current study.
Grasso et al. studied MBL2 genetic polymorphisms
in Italian children with adenotonsillar hypertrophy,

and found that the MBL2 00 genotype could be used
as a prognostic marker in subjects with adenotonsillar
hypertrophy.
Studies suggested that gene interaction is not only
possible but is probably ubiquitous for determining
susceptibility to complex human diseases (11). Further
studies on the interactions are therefore warranted to
elucidate their possible underlying role in the pathogenesis
and delineation of pathways leading to AH.
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